HSP110, caspase-3 and -9 expression in physiological apoptosis and apoptosis induced by in vivo embryonic exposition to all-trans retinoic acid or irradiation during early mouse eye development.
Apoptosis is an essential physiological process in embryonic development. In the developing eye of vertebrates, three periods of developmental apoptosis can be distinguished: early, intermediate and later. Within the apoptosis pathway, caspases play a crucial role. It has also been shown that HSP110 may have a potential role in apoptosis. The aim of this research was to study the expression of HSP110, caspase-3 and -9 in physiological, retinoic- or irradiation-induced apoptosis during early eye development. Seven pregnant C57Bl/6J mice received 80 mg kg(-1) of all-trans retinoic acid mixed with sesame oil. Seven pregnant NMRI mice received 2 Gy irradiation at the same gestational day. Control mice of both strains (seven mice of each) were not submitted to any treatment. Embryos were harvested at 3, 6, 12 and 24 h after exposition, fixed, dehydrated and embedded. Coronal sections (5 microm) were made. Slide staining occurred alternatively using anti-caspase-3, anti-caspase-9 and anti-HSP110 immunohistochemistry. HSP110 and caspase-3 expression presented similar topographic and chronological patterns, whereas expression of HSP110 was more precocious in retinoic acid-treated embryos. After retinoic exposure, caspase-3- and HSP110-positive cells were increased in the region of the optic vesicle. By contrast, after irradiation, caspase-3- and HSP110-positive cells were noticeably increased in the optic vesicle, peri-optical mesoderm but less in lens placode. HSP110 was expressed before caspase-3. By contrast, caspase-9 was expressed by a very small number of cells in the optic vesicle either under physiological or under teratogenic conditions. Thus, it seems that activation of caspase-9 is dispensable in early eye developmental apoptosis.
Gashegu
Julien
J
Department of Anatomy and Embryology, Université Libre de Bruxelles, Faculty of Medicine, Brussels, Belgium.
Ladha
Reza
R
Vanmuylder
Nathalie
N
Philippson
Catherine
C
Bremer
Françoise
F
Rooze
Marcel
M
Louryan
Stéphane
S
D000014:Abnormalities, Drug-Induced / Q000378:metabolism; D000016:Abnormalities, Radiation-Induced / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000528:radiation effects; D053148:Caspase 3 / Q000032:analysis*; D053453:Caspase 9 / Q000032:analysis*; D047108:Embryonic Development / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D005123:Eye / Q000187:drug effects / Q000196:embryology* / Q000528:radiation effects; D005260:Female; D005865:Gestational Age; D050957:HSP110 Heat-Shock Proteins / Q000032:analysis*; D007150:Immunohistochemistry; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D023421:Models, Animal; D011247:Pregnancy; D013723:Teratogens / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
D050957:HSP110 Heat-Shock Proteins; D013723:Teratogens; D014212:Tretinoin; D053148:Caspase 3; D053453:Caspase 9